Stay updated on Avutometinib and Defactinib in Thyroid Cancer Clinical Trial

Sign up to get notified when there's something new on the Avutometinib and Defactinib in Thyroid Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Avutometinib and Defactinib in Thyroid Cancer Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error page with the standard site header and footer, indicating access to the study content is blocked.
    Difference
    19%
    Check dated 2026-09-20T01:18:41.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    Revision updated from v3.6.5 to v3.6.6. This change reflects a page-level update/patch and does not alter study details or core content.
    Difference
    0.1%
    Check dated 2026-08-29T21:58:29.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    The page revision was incremented from v3.6.4 to v3.6.5, indicating a minor update to the page. No visible content changes are indicated by this revision bump.
    Difference
    0.0%
    Check dated 2026-08-08T18:18:07.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The page revision label was updated to v3.6.4, replacing the previous v3.6.3. This signals a new version of the page content.
    Difference
    0.0%
    Check dated 2026-07-25T11:52:54.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.3, replacing the previous Revision: v3.6.2. This indicates a minor system update.
    Difference
    0.0%
    Check dated 2026-07-03T23:23:31.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    An updated study overview was added, detailing the evaluation of avutometinib and defactinib for RAF dimer-driven thyroid cancers and the safety profile. The FDA OOPD funding line was added, and the previous version of the description and its revision notes was removed.
    Difference
    0.3%
    Check dated 2026-06-26T23:54:11.000Z thumbnail image

Stay in the know with updates to Avutometinib and Defactinib in Thyroid Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Avutometinib and Defactinib in Thyroid Cancer Clinical Trial page.